130 related articles for article (PubMed ID: 15334150)
1. [Ziprasidone and dementia].
Aakhus E
Tidsskr Nor Laegeforen; 2004 Aug; 124(16):2155-6; author reply 2155-6. PubMed ID: 15334150
[No Abstract] [Full Text] [Related]
2. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
[No Abstract] [Full Text] [Related]
3. Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone.
Kuwilsky A; Krumm B; Englisch S; Dressing H; Zink M
Pharmacopsychiatry; 2010 Aug; 43(6):216-20. PubMed ID: 20589598
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of ziprasidone: an expanding perspective.
Daniel DG
J Clin Psychiatry; 2003; 64 Suppl 19():40-9. PubMed ID: 14728089
[TBL] [Abstract][Full Text] [Related]
5. Ziprasidone (Geodon) for schizophrenia.
Med Lett Drugs Ther; 2001 Jun; 43(1106):51-2. PubMed ID: 11402259
[No Abstract] [Full Text] [Related]
6. Possible ziprasidone-induced mania.
Larson MF; Hauser A
J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1012; discussion 1012-3. PubMed ID: 12964565
[No Abstract] [Full Text] [Related]
7. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
Scahill L; Blair J; Leckman JF; Martin A
J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
[No Abstract] [Full Text] [Related]
8. Parkinsonism with intramuscular ziprasidone.
Bilal L; Tsai C; Gasper JJ; Ndlela JC
Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
[No Abstract] [Full Text] [Related]
9. Ziprasidone-induced oculogyric crisis.
Ramos AE; Shytle RD; Silver AA; Sanberg PR
J Am Acad Child Adolesc Psychiatry; 2003 Sep; 42(9):1013-4. PubMed ID: 12964566
[No Abstract] [Full Text] [Related]
10. Ziprasidone-induced acute dystonia.
Mason MN; Johnson CE; Piasecki M
Am J Psychiatry; 2005 Mar; 162(3):625-6. PubMed ID: 15741487
[No Abstract] [Full Text] [Related]
11. Ziprasidone and hypomania.
Duggal HS; Singh I
CNS Spectr; 2005 Aug; 10(8):606; author reply 606. PubMed ID: 16173129
[No Abstract] [Full Text] [Related]
12. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
Gray NS
Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
[TBL] [Abstract][Full Text] [Related]
13. Ziprasidone and migraine headache.
Boeker T
Am J Psychiatry; 2002 Aug; 159(8):1435-6. PubMed ID: 12153843
[No Abstract] [Full Text] [Related]
14. Tardive dyskinesia and ziprasidone.
Rosenquist KJ; Walker SS; Ghaemi SN
Am J Psychiatry; 2002 Aug; 159(8):1436. PubMed ID: 12153846
[No Abstract] [Full Text] [Related]
15. Repeated acute dystonia following administration of amisulpride and ziprasidone in a patient with iron deficiency.
Chen HK; Chen CK; Tzeng NS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1615-6. PubMed ID: 18597910
[No Abstract] [Full Text] [Related]
16. [Therapeutic gap when it comes to behavioral symptoms and psychoses among the elderly].
Nygaard HA
Tidsskr Nor Laegeforen; 2004 Oct; 124(19):2515. PubMed ID: 15477898
[No Abstract] [Full Text] [Related]
17. Ziprasidone-associated pedal edema in the treatment of schizophrenia.
Ku HL; Su TP; Chou YH
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):963-4. PubMed ID: 16624468
[TBL] [Abstract][Full Text] [Related]
18. [Ziprasidone. A new second-generation antipsychotic agent].
Lublin HK
Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
[No Abstract] [Full Text] [Related]
19. [Atypical antipsychotics and dementia].
Sundal E
Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2664. PubMed ID: 15534657
[No Abstract] [Full Text] [Related]
20. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
Montejo AL; Rico-Villademoros F;
J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
[No Abstract] [Full Text] [Related]
[Next] [New Search]
